Currently our primary research objective is to encourage and assist the development of better and faster measures of genome-engineering journals. In cases where we believe we can contribute directly, as opposed to through highlighting the work of others, we are producing our own measures of research activity. Our work is mainly of interest to investors, organizations and individuals in the financial sector and to significant corporations with global operations, as well as governments and academic researchers. Genome-engineering play a key role in the knowledge societies and this knowledge is rising by leaps and bounds within no time. Scientists and academicians require a broad understanding of the latest updates in the respective discipline for their professional and learning endeavors.